Qi-fei Tao
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 2
- Molecular Biology top 5%
- RNA modifications and cancer 5
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Liver Disease Diagnosis and Treatment 4
- Hepatitis B Virus Studies 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Cancer Mechanisms and Therapy 2
In The Last Decade
Qi-fei Tao
17 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Cancer Research 1.8k
- Molecular Biology 1.8k
- Hepatology 86
- Epidemiology 233
- Oncology 170
Countries citing papers authored by Qi-fei Tao
This map shows the geographic impact of Qi-fei Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi-fei Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi-fei Tao more than expected).
Fields of papers citing papers by Qi-fei Tao
This network shows the impact of papers produced by Qi-fei Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi-fei Tao. The network helps show where Qi-fei Tao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qi-fei Tao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 7 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 5 | |
| 7 | 2019 | 9 | |
| 8 | 2019 | 20 | |
| 9 | 2017 | 249 | |
| 10 | 2016 | 11 | |
| 11 | 2016 | 5 | |
| 12 | 2015 | 65 | |
| 13 | 2014 | 49 | |
| 14 | 2014 | 84 | |
| 15 | A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinomabreakdown → | 2014 | 1279 |
| 16 | 2013 | 20 | |
| 17 | 2012 | 333 |
About Qi-fei Tao
Qi-fei Tao is a scholar working on Hepatology, Cancer Research and Clinical Biochemistry, having authored 17 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Hepatitis B Virus Studies (3 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (1.8k citations) and Hepatology (86 citations). Qi-fei Tao has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Weiping Zhou, Shuhan Sun, Yuan Yang, Fu Yang, Ji‐hang Yuan, Tian-tian Wang, Wei Pan, Chuanchuan Zhou, Jinzhao Ma and Guang-Shun Yang. Their work appears in journals such as Nature Cell Biology, Hepatology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.